共查询到20条相似文献,搜索用时 15 毫秒
1.
2.
3.
Jonathan M. G. Higgins 《Chromosoma》2010,119(2):137-147
The haspins are divergent members of the eukaryotic protein kinase family that are conserved in many eukaryotic lineages including
animals, fungi, and plants. Recently-solved crystal structures confirm that the kinase domain of human haspin has unusual
structural features that stabilize a catalytically active conformation and create a distinctive substrate binding site. Haspin
localizes predominantly to chromosomes and phosphorylates histone H3 at threonine-3 during mitosis, particularly at inner
centromeres. This suggests that haspin directly regulates chromosome behavior by modifying histones, although it is likely
that additional substrates will be identified in the future. Depletion of haspin by RNA interference in human cell lines causes
premature loss of centromeric cohesin from chromosomes in mitosis and failure of metaphase chromosome alignment, leading to
activation of the spindle assembly checkpoint and mitotic arrest. Haspin overexpression stabilizes chromosome arm cohesion.
Haspin, therefore, appears to be required for protection of cohesion at mitotic centromeres. Saccharomyces cerevisiae homologues of haspin, Alk1 and Alk2, are also implicated in regulation of mitosis. In mammals, haspin is expressed at high
levels in the testis, particularly in round spermatids, so it seems likely that haspin has an additional role in post-meiotic
spermatogenesis. Haspin is currently the subject of a number of drug discovery efforts, and the future use of haspin inhibitors
should provide new insight into the cellular functions of these kinases and help determine the utility of, for example, targeting
haspin for cancer therapy. 相似文献
4.
Histone modification, a post-translational modification of histones and involving various covalent tags, such as methyl, phosphate and acetate groups, affects gene expression and hence modulates various cellular events, including growth and proliferation. Consequently histone-modifying proteins have become targets for the development of anticancer agents. Thus far, compounds that inhibit the methylation or acetylation of histones have advanced in the clinic, but inhibitors of histone phosphorylation have lagged behind. Haspin is a kinase that phosphorylates histone H3 and is a promising anticancer target. Thus far only a handful of haspin inhibitors have been reported. Using a one-flask Doebner/Povarov reaction, we synthesized a library of compounds that potently inhibit haspin with IC50 values as low as 14 nM. Some of these compounds also inhibited the proliferation of cancer cell lines HCT116, HeLa and A375. The ease of synthesis of the new haspin inhibitors, coupled with their anticancer activities make these compounds interesting leads to develop into therapeutics. 相似文献
5.
Cuny GD Ulyanova NP Patnaik D Liu JF Lin X Auerbach K Ray SS Xian J Glicksman MA Stein RL Higgins JM 《Bioorganic & medicinal chemistry letters》2012,22(5):2015-2019
Haspin is a serine/threonine kinase that phosphorylates Thr-3 of histone H3 in mitosis that has emerged as a possible cancer therapeutic target. High throughput screening of approximately 140,000 compounds identified the beta-carbolines harmine and harmol as moderately potent haspin kinase inhibitors. Based on information obtained from a structure-activity relationship study previously conducted for an acridine series of haspin inhibitors in conjunction with in silico docking using a recently disclosed crystal structure of the kinase, harmine analogs were designed that resulted in significantly increased haspin kinase inhibitory potency. The harmine derivatives also demonstrated less activity towards DYRK2 compared to the acridine series. In vitro mouse liver microsome stability and kinase profiling of a representative member of the harmine series (42, LDN-211898) are also presented. 相似文献
6.
Peiling Wang Xiangmei Hua Yuge Han Bryner Sijing Liu Christopher B. Gitter Jun Dai 《Journal of cellular physiology》2020,235(5):4508-4519
Haspin (Haploid Germ Cell-Specific Nuclear Protein Kinase) is a serine/threonine kinase pertinent to normal mitosis progression and mitotic phosphorylation of histone H3 at threonine 3 in mammalian cells. Different classes of small molecule inhibitors of haspin have been developed and utilized to investigate its mitotic functions. We report herein that applying haspin inhibitor CHR-6494 or 5-ITu at the G1/S boundary could delay mitotic entry in synchronized HeLa and U2OS cells, respectively, following an extended G2 or the S phase. Moreover, late application of haspin inhibitors at S/G2 boundary is sufficient to delay mitotic onset in both cell lines, thereby, indicating a direct effect of haspin on G2/M transition. A prolonged interphase duration is also observed with knockdown of haspin expression in synchronized and asynchronous cells. These results suggest that haspin can regulate cell cycle progression at multiple stages at both interphase and mitosis. 相似文献
7.
《Cell cycle (Georgetown, Tex.)》2013,12(5):665-668
The fidelity of chromosome segregation during cell division is critical to maintaingenomic stability and to prevent cancer and birth defects. A key set of kinases that regulates thisprocess has been identified and characterized over the last few years, including the Aurora, Poloand Nek families. Recently we proposed that a little-studied kinase known as haspin is a newmember of this important group. During mitosis haspin is phosphorylated, associates with thechromosomes, centrosomes and spindle, and is responsible for phosphorylation of histone H3 atthreonine-3. Depletion of haspin using RNA interference prevents normal alignment ofchromosomes at metaphase, suggesting that haspin plays a crucial role in chromosomesegregation. Here we discuss possible mechanisms of haspin action and the function of histonephosphorylation in mitosis. We also outline some of the questions raised by these new findingsand consider what role haspin might play in cancer. 相似文献
8.
Gregory D. Cuny Maxime Robin Natalia P. Ulyanova Debasis Patnaik Valerie Pique Gilles Casano Ji-Feng Liu Xiangjie Lin Jun Xian Marcie A. Glicksman Ross L. Stein Jonathan M.G. Higgins 《Bioorganic & medicinal chemistry letters》2010,20(12):3491-3494
Haspin is a serine/threonine kinase required for completion of normal mitosis that is highly expressed during cell proliferation, including in a number of neoplasms. Consequently, it has emerged as a potential therapeutic target in oncology. A high throughput screen of approximately 140,000 compounds identified an acridine analog as a potent haspin kinase inhibitor. Profiling against a panel of 270 kinases revealed that the compound also exhibited potent inhibitory activity for DYRK2, another serine/threonine kinase. An optimization study of the acridine series revealed that the structure–activity relationship (SAR) of the acridine series for haspin and DYRK2 inhibition had many similarities. However, several structural differences were noted that allowed generation of a potent haspin kinase inhibitor (33, IC50 <60 nM) with 180-fold selectivity over DYRK2. In addition, a moderately potent DYRK2 inhibitor (41, IC50 <400 nM) with a 5.4-fold selectivity over haspin was also identified. 相似文献
9.
10.
11.
12.
13.
14.
15.
16.
Elena Baena-Gonzlez Sacha Baginsky Paula Mulo Holger Summer Eva-Mari Aro Gerhard Link 《Plant physiology》2001,127(3):1044-1052
17.
18.
19.
20.
Patnaik D Jun Xian Glicksman MA Cuny GD Stein RL Higgins JM 《Journal of biomolecular screening》2008,13(10):1025-1034
Haspin/Gsg2 is a kinase that phosphorylates histone H3 at Thr-3 (H3T3ph) during mitosis. Its depletion by RNA interference results in failure of chromosome alignment and a block in mitosis. Haspin, therefore, is a novel target for development of antimitotic agents. We report the development of a high-throughput time-resolved fluorescence resonance energy transfer (TR-FRET) kinase assay for haspin. Histone H3 peptide was used as a substrate, and a europium-labeled H3T3ph phosphospecific monoclonal antibody was used to detect phosphorylation. A library of 137632 small molecules was screened at K(m) concentrations of ATP and peptide to allow identification of diverse inhibitor types. Reconfirmation of hits and IC( 50) determinations were carried out with the TR-FRET assay and by a radiometric assay using recombinant histone H3 as the substrate. A preliminary assessment of specificity was made by testing inhibition of 2 unrelated kinases. EC( 50) values in cells were determined using a cell-based ELISA of H3T3ph. Five compounds were selected as leads based on potency and chemical structure considerations. These leads form the basis for the development of specific inhibitors of haspin that will have clear utility in basic research and possible use as starting points for development of antimitotic anticancer therapeutics. 相似文献